Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings (MEDP)
NASDAQ:MEDP
Total Valuation
Medpace Holdings has a market cap or net worth of $8.79B. The enterprise value is $7.04B.
Market Cap$8.79B
Enterprise Value$7.04B
Share Statistics
Medpace Holdings has 28,741,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,741,610
Owned by Insiders20.54%
Owned by Institutions30.09%
Financial Efficiency
Medpace Holdings’s return on equity (ROE) is 0.49 and return on invested capital (ROIC) is 38.11%.
Return on Equity (ROE)0.49
Return on Assets (ROA)0.19
Return on Invested Capital (ROIC)38.11%
Return on Capital Employed (ROCE)0.45
Revenue Per Employee357.47K
Profits Per Employee68.54K
Employee Count5,900
Asset Turnover1.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medpace Holdings is 25.43. Medpace Holdings’s PEG ratio is 0.57.
PE Ratio25.43
PS Ratio0.00
PB Ratio17.80
Price to Fair Value12.46
Price to FCF19.59
Price to Operating Cash Flow17.73
PEG Ratio0.57
Income Statement
In the last 12 months, Medpace Holdings had revenue of 2.11B and earned 404.39M in profits. Earnings per share was 13.06.
Revenue2.11B
Gross Profit656.30M
Operating Income446.87M
Pretax Income475.92M
Net Income404.39M
EBITDA476.12M
Earnings Per Share (EPS)13.06
Cash Flow
In the last 12 months, operating cash flow was 581.97M and capital expenditures -41.05M, giving a free cash flow of 540.93M billion.
Operating Cash Flow581.97M
Free Cash Flow540.93M
Free Cash Flow per Share18.82
Dividends & Yields
Medpace Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.11
52-Week Price Change-25.12%
50-Day Moving Average298.69
200-Day Moving Average330.00
Relative Strength Index (RSI)51.11
Average Volume (3m)331.92K
Important Dates
Medpace Holdings upcoming earnings date is Jul 28, 2025, TBA Not Confirmed.
Last Earnings DateApr 21, 2025
Next Earnings DateJul 28, 2025
Ex-Dividend Date―
Financial Position
Medpace Holdings as a current ratio of 0.93, with Debt / Equity ratio of 48.88%
Current Ratio0.93
Quick Ratio0.93
Debt to Market Cap0.00
Net Debt to EBITDA-1.14
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medpace Holdings has paid 71.54M in taxes.
Income Tax71.54M
Effective Tax Rate0.15
Enterprise Valuation
Medpace Holdings EV to EBITDA ratio is 20.46, with an EV/FCF ratio of 17.02.
EV to Sales4.62
EV to EBITDA20.46
EV to Free Cash Flow17.02
EV to Operating Cash Flow16.00
Balance Sheet
Medpace Holdings has $441.44M in cash and marketable securities with $126.66M in debt, giving a net cash position of -$314.78M billion.
Cash & Marketable Securities$441.44M
Total Debt$126.66M
Net Cash-$314.78M
Net Cash Per Share-$10.95
Tangible Book Value Per Share$4.16
Margins
Gross margin is 29.62%, with operating margin of 21.19%, and net profit margin of 19.17%.
Gross Margin29.62%
Operating Margin21.19%
Pretax Margin22.57%
Net Profit Margin19.17%
EBITDA Margin22.58%
EBIT Margin21.19%
Analyst Forecast
The average price target for Medpace Holdings is $318.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$318.50
Price Target Upside5.36% Upside
Analyst ConsensusHold
Analyst Count7
Revenue Growth Forecast9.87%
EPS Growth Forecast32.81%